<p><b>TABLE OF INTERACTIONS WITH</b></p>

<p><b>ACETYLCHOLINESTERASE INHIBITORS</b></p>

<p><b>See also: bradycardia inducing drugs</b></p>

<p><b>+ ATROPINIC MEDICATIONS</b></p>

<p><b>It is necessary to take into account the risk of administering an atropinic medication (tricyclic antidepressants, neuroleptics, phenothiazines, antispasmotics, some H1-antihistamines …) to a patient also taking an anticholinasterase. Aside from the possible decrease of the therapeutic effect of the latter, the abrupt interruption of treatment with an atopinic exposes the patient to the risk of uncovering the muscarinic effects of the parasympathomimetic with symptoms of the “cholinergic crisis” type, which can manifest especially with convulsions. </b></p>

<p><b>+OTHER ANTI-CHOLINESTERASE MEDICATIONS</b></p>

<p><b>It is necessary to take into account the administration of an anticholinasterase, given for a diagnosis such as for myasthenia or intestinal atonia, with another anticholinsaterase given for Alzheimers, due to the risks of additive undesirable effects of the cholinergic type, especially digestive ones.</b></p>

<p><b>From the French ANSM drug interactions document of September 2016, p. 19</b></p>

<table cellspacing="0" cellpadding="0" border="1">
<tbody>
<tr>
<td valign="top"><p><b>ACETYL-CHOLINESTERASE INHIBITORS</b></p>

<p><b>CLASS CODE: ACETCHO</b></p></td>
<td valign="top"><p><b>BETA-BLOCKING AGENTS IN HEART FAILURE</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C07AB-003</b></p></td>
<td valign="top"><p>Risk of excessive bradycardia (addition of the bradycardia inducing effects)</p>

</td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Regular clinical monitoring, especially at the beginning of the administration of the substances together </p></td>
</tr>

<tr>
<td valign="top"><p><b>ACETYL-CHOLINESTERASE INHIBITORS</b></p>

<p><b>CLASS CODE: ACETCHO</b></p></td>
<td valign="top"><p><b>PILOCARPINE</b></p>

<p><b>RxNorm: 8328</b></p>

<p><b>ATC: </b></p>

<p><b>N07AX01 S01EB01 </b></p>

<p><b>S01EB51</b></p></td>
<td valign="top"><p>Risk of addition of the undesirable cholinergic effects, especially digestive ones</p></td>
<td valign="top"><p><b>Take into account</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>ACETYL-CHOLINESTERASE INHIBITORS</b></p>

<p><b>CLASS CODE: ACETCHO</b></p></td>
<td valign="top"><p><b>SUXAMETHONIUM</b></p>

<p><b>RxNorm: 10154 </b></p>

<p><b>ATC: M03AB01</b></p></td>
<td valign="top"><p>Risk of lengthening of the motor block, increased in the case of partial deficit of pseudocholinesterase</p></td>
<td valign="top"><p><b>Take into account</b></p></td>
</tr>

</tbody>
</table>

